thanks for your opinion. I think I'll get in now. I remember waffling a little with IMMU this summer and it tripled on me fast. Without me - because I waffled. So I'll jump in here now - even though it's shot up remarkably from my first survey a few days ago! I've watched Atala's technology for years. I do think the market is nearly ready for it now. Also - tngn has streamlined their process unbelievably in the past couple of years, reducing turnaround time for the cell-seeded scaffolds from 7 weeks to 4. They are remarkable. And I am so glad they are not pursuing their bladder augmentation technology and instead are pursuing the neo-conduit. Smart move.
Market Data 
Markets 
AI
